TRANSLATION, TRANSCULTURAL ADAPTATION, AND ANALYSIS OF THE MEASUREMENT PROPERTIES OF THE BRAZILIAN PORTUGUESE VERSION OF THE GENERAL SCALE OF NEUROPATHIC LIMITATIONS (ONLS) QUESTIONNAIRE
DOI:
https://doi.org/10.56238/levv16n55-016Keywords:
Peripheral Neuropathies, Scales, TranslationAbstract
The aim of this study was to describe the process of translation and cross-cultural adaptation of the Brazilian version of the Overall Neuropathy Limitations Scale (ONLS) to the General Scale of Neuropathic Limitations (EGLN) into Brazilian Portuguese. The translated version of the ONLS was applied in a pilot sample with 30 patients in person and then an expanded sample was carried out with 100 patients where 81.0% of the scale was applied remotely and (Teleconference), and 19.0% of the scale were applied face-to-face. The participating patients were 60.0% male and 40.0% female. Cronbach's alpha for the pilot sample of the upper limb was 0.77, for the lower limbs it was 0.49. Enlarged sample with 100 patients for upper limbs was 0.68, and for lower limbs it was 0.34.
Downloads
References
1. Landgren O, Gridley G, Turesson I, Caporaso NE, Goldin LR, Baris D, et al. Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States. Blood. 2006;107(3):904–6. doi: 10.1182/blood-2005-08-3449
2. Hartung HP, van der Meché FGA, Pollard JD. Guillain–Barré syndrome, CIDP and other chronic immune-mediated neuropathies. Curr Opin Neurol. 1998;11(5):497–513. doi: 10.1097/00019052-199810000-00013
3. Medical Research Council. Aids to the investigation of the peripheral nervous system. London: Her Majesty’s Stationery Office; 1943.
4. World Health Organization. International classification of impairments, disabilities, and handicaps. Geneva: WHO; 1980.
5. Hughes RAC, Sharrack B. Measuring disablement and quality of life in multiple sclerosis. Eur J Neurol. 1998;5(Suppl 2):S41–2.
6. Sharrack B, Hughes RAC. Clinical scales for multiple sclerosis. J Neurol Sci. 1996;135:1–9. doi: 10.1016/0022-510x(95)00261-y
7. Graham RC, Hughes RAC. A modified peripheral neuropathy scale: the Overall Neuropathy Limitations Scale. J Neurol Neurosurg Psychiatry. 2006;77(3):973–6. doi: 10.1136/jnnp.2005.081547
8. Merkies IS, Schmitz PI, van der Meche FGA, Samijn JPÀ, Doorn PA, Inflammatory Neuropathy Cause and Treatment (INCAT) group. Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies. J Neurol Neurosurg Psychiatry. 2002;72:596–601. doi: 10.1136/jnnp.72.5.596
9. Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine (Phila Pa 1976). 2000;25(24):3186–91. doi: 10.1097/00007632-200012150-00014
10. Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Recommendations for the cross-cultural adaptation of healthy status measures. American Academy of Orthopaedic Surgeons Institute for Work & Health; 2002.
11. Nusbaum L, Natour J, Ferraz MB, Goldenberg J. Translation, adaptation and validation of the Roland-Morris questionnaire - Brazil Roland-Morris. Braz J Med Biol Res. 2001;34(2):203–10. doi: S0100-879X2001000200007
12. Gao X, Huang X, Cao X, Zhou D, Xia W, Li J, et al. Endocrine evaluation in POEMS Syndrome: a Cohort study. Front Endocrinol (Lausanne). 2020;11:536241. doi: 10.3389/fendo.2020.536241
13. Zis P, Sarrigiannis PG, Rao DG, Hewamadduma C, Hadjivassiliou M. Chronic idiopathic axonal polyneuropathy: prevalence of pain and impact on quality of life. Brain Behav. 2019;9(1):e01171. doi: 10.1002/brb3.1171
14. Graham RC, Hughes RA. Clinimetric properties of a walking scale in peripheral neuropathy. J Neurol Neurosurg Psychiatry. 2006;77(8):977–9. doi: 10.1136/jnnp.2005.081497
15. Solari A, Laura M, Salsano E, Radice D, Pareyson D. Reliability of clinical outcome measures in Charcot-Marie-Tooth disease. Neuromuscul Disord. 2008;18(1):19–26. doi: 10.1016/j.nmd.2007.09.006
16. Terwee CB, Bot SD, de Boer MR, van der Windt DA, Knol DL, Dekker J, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60(1):34–42. doi: 10.1016/j.jclinepi.2006.03.012
17. Zivi I, Maffia S, Ferrari V, Zarucchi A, Molatore K, Maestri R, et al. Effectiveness of aquatic versus land physiotherapy in the treatment of peripheral neuropathies: a randomized controlled trial. Clin Rehabil. 2018;32(5):663–70. doi: 10.1177/0269215517746716
18. Spina E, Trojsi F, Tozza S, Iovino A, Iodice R, Passaniti C, et al. How to manage with telemedicine people with neuromuscular diseases? Neurol Sci. 2021;42(9): 3553–9. doi: 10.1007/s10072-021-05396-8
